Dr.Reddy's Laboratories Ltd (RDY)
27 Jun 2017
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|49||2014||Chairman of the Board|
|56||2014||Co-Chairman of the Board, Chief Executive Officer, Managing Director|
|55||2012||President, Chief Financial Officer, Global Head - HR and IT & BPE|
|59||2013||President, Global Head - Human Resources|
|58||2014||Chief Operating Officer|
- BRIEF-Dr. Reddy's Lab says USFDA issues form 483 with one observation for Srikakulam Plant
- BRIEF-Dr.Reddy's Labs recalls Cipla-made zenatane capsule from U.S. markets
- BRIEF-Dr.Reddy's Labs gets EIR as closure of audit of Miryalaguda API manufacturing plant
- BRIEF-Dr.Reddy's Laboratories announces launch of Bivalirudin for injection in U.S. market
- BRIEF-Dr.Reddy's Labs' audit of formulations Srikakulum plant Unit II completed with zero observations